Five things to know to start your day

Nigeria engages IFC for N12.3b to fund vaccine production

The coronavirus pandemic laid bare the desperate need for a local facility for Africa’s most populous nation

Local vaccine production could cost Nigeria more than Pfizer, AstraZeneca’s A locally developed COVID-19 vaccine prospect in Nigeria, listed by the World Health Organisation (WHO) among 183 others in preclinical trials globally, might cost more to manufacture than the relatively pricey Pfizer-B

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```